THE USE OF THE DRUGS AB 103 AND AB 132 IN THE COMBINED TREATMENT OF TUMOURS OF THE CERVICAL AND PULMONARY REGIONS.
D000477:Alkylating Agents; D000970:Antineoplastic Agents; D001388:Aziridines; D002219:Carbamates; D002283:Carcinoma, Bronchogenic; D002294:Carcinoma, Squamous Cell; D005853:Geriatrics; D006258:Head and Neck Neoplasms; D006801:Humans; D008175:Lung Neoplasms; D016403:Lymphoma, Large B-Cell, Diffuse; D008228:Lymphoma, Non-Hodgkin; D008441:Maxillary Neoplasms; D009369:Neoplasms / Q000532:radiotherapy*; D010307:Parotid Neoplasms; D010610:Pharyngeal Neoplasms; D012509:Sarcoma; D014062:Tongue Neoplasms
D000477:Alkylating Agents; D000970:Antineoplastic Agents; D001388:Aziridines; D002219:Carbamates; C024217:meturedepa
ALKYLATING AGENTS; ANTINEOPLASTIC AGENTS; CARBAMATES; CARCINOMA, BRONCHOGENIC; CARCINOMA, EPIDERMOID; GERIATRICS; LUNG NEOPLASMS; MAXILLARY NEOPLASMS; NECK NEOPLASMS; NEOPLASM RADIOTHERAPY; PAROTID NEOPLASMS; PHARYNGEAL NEOPLASMS; SARCOMA, RETICULUM CELL; TONGUE NEOPLASMS